Orthopedic Surgery Doctors in Hanford, CA Accepting Medicare

3 Orthopedic Surgery doctors found. Showing 1 - 3

Dr. Christopher Alan Verioti, D.O. Orthopaedic Surgery - Sports Medicine Medicare: Medicare Enrolled Practice Location: 125 Mall Dr Ste 211a, Hanford, CA 93230 Phone: 559-537-0330    Fax: 559-537-0332

Dr. Anuj Varshney, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 125 Mall Dr Ste 303, Hanford, CA 93230 Phone: 559-537-0313

Dr. Kenny T. Mai, M.D, Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 870 W. Seventh Street, Hanford, CA 93230 Phone: 559-582-9621    Fax: 559-582-9622

News Archive

School students eat less fruits and vegetables despite national push for healthier school lunches

Less than a month before Congress votes on whether to reauthorize a controversial program mandating healthier school lunches, a new study confirms the suspicions of school officials - many students are putting the fruits and vegetables they're now required to take straight into the trash, consuming fewer than they did before the law took effect.

Test for motile sperm improves ICSI outcomes

Researchers have developed a new sperm test that could improve pregnancy rates among women treated with intracytoplasmic sperm injection.

Researchers estimate prevalence of SARS-CoV-2 antibodies among adults in orange county

Testing a representative sample of Orange County residents for a wide range of coronavirus antibodies, University of California, Irvine researchers found that 11.5 percent of them have antibodies for COVID-19, in contrast to previous estimates of less than 2 percent.

MarketWatch examines costs of high-deductible health plans for women

Although "little research" has been conducted on the effects of high-deductible health plans on women, "several studies point to potentially higher costs, ... especially where maternity care is concerned," MarketWatch reports.

Health reform updates: Biotech grants, privacy issues and birth control coverage

Firms vying to tap the fund a $1 billion fund meant to catalyze research on new biologic treatments for cancer and other diseases may be disappointed in the outcome, The Washington Post reports. "[W]ith so many companies applying for a share of the money, many firms got much smaller allotments than requested and said the financial boost won't go as far as they had initially hoped.

Read more Medical News

› Verified 3 days ago